416 related articles for article (PubMed ID: 24853620)
1. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
[TBL] [Abstract][Full Text] [Related]
2. Identification of pharmaceutical impurities in formulated dosage forms.
Pan C; Liu F; Motto M
J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
[TBL] [Abstract][Full Text] [Related]
3. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
Liu DQ; Sun M; Wu L
Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
[TBL] [Abstract][Full Text] [Related]
4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
5. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic Separation and NMR An Integrated Approach in Pharmaceutical Development.
Gonnella NC
Adv Chromatogr; 2012; 50():93-138. PubMed ID: 26437511
[TBL] [Abstract][Full Text] [Related]
7. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
Ramachandra B
Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
[TBL] [Abstract][Full Text] [Related]
8. Determination of d-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC-UV Method and the DOSY NMR Method.
Makuc D; Švab Ž; Naumoska K; Plavec J; Časar Z
Molecules; 2020 Apr; 25(7):. PubMed ID: 32272592
[TBL] [Abstract][Full Text] [Related]
9. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.
Norwood DL; Mullis JO; Davis M; Pennino S; Egert T; Gonnella NC
PDA J Pharm Sci Technol; 2013; 67(3):267-87. PubMed ID: 23752753
[TBL] [Abstract][Full Text] [Related]
10. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
11. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
Prajapati KJ; Kothari CS
Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
[TBL] [Abstract][Full Text] [Related]
14. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
15. Separation and analysis of trace degradants in a pharmaceutical formulation using on-line capillary isotachophoresis-NMR.
Eldridge SL; Almeida VK; Korir AK; Larive CK
Anal Chem; 2007 Nov; 79(22):8446-53. PubMed ID: 17929948
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.
Raman NV; Prasad AV; Ratnakar Reddy K
J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280
[TBL] [Abstract][Full Text] [Related]
17. Hyphenated HPLC-NMR and its applications in drug discovery.
Peng SX
Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
[TBL] [Abstract][Full Text] [Related]
19. Semi-preparative LC-SPE-cryoflow NMR for impurity identifications: use of mother liquor as a better source of impurities.
Rinaldi F; Fan J; Pathirana C; Palaniswamy V
Magn Reson Chem; 2013 Sep; 51(9):517-22. PubMed ID: 23788325
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple impurities in a pharmaceutical matrix using preparative gas chromatography and computer-assisted structure elucidation.
Codina A; Ryan RW; Joyce R; Richards DS
Anal Chem; 2010 Nov; 82(21):9127-33. PubMed ID: 20942391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
